Carfilzomib · 2026 04 06
Isatuximab, carfilzomib, lenalidomide and dexamethasone in newly diagnosed multiple myeloma: a randomized phase 3 trial.
Journal Article, Randomized Controlled Trial, Clinical Trial, Phase III
Open attributed record →PubMed-attributed venue
4 selected PubMed bibliographic records attributed to Nature medicine. Venue attribution is reproduced from PubMed and does not imply endorsement, editorial affiliation, article quality, or scientific validity.
4 selected records.
4 connected profiles.
2 attributed years.
Attributed bibliography
Carfilzomib · 2026 04 06
Journal Article, Randomized Controlled Trial, Clinical Trial, Phase III
Open attributed record →Semaglutide · 2026 03 02
Journal Article, Randomized Controlled Trial, Clinical Trial, Phase II
Open attributed record →Trofinetide · 2023 06 08
Clinical Trial, Phase III, Randomized Controlled Trial, Journal Article, Research Support, Non-U.S. Gov't
Open attributed record →Motixafortide · 2023 04 17
Clinical Trial, Phase III, Randomized Controlled Trial, Multicenter Study, Journal Article, Research Support, N.I.H., Extramural, Equivalence Trial
Open attributed record →